MOG (35-55) structure
|
Common Name | MOG (35-55) | ||
|---|---|---|---|---|
| CAS Number | 163913-87-9 | Molecular Weight | 2581.98 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C118H177N35O29S | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
| Name | mog (35-55) |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C118H177N35O29S |
|---|---|
| Molecular Weight | 2581.98 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Post intoxicative therapeutic immunization with myelin oligodendrocyte glycoproteine (MOG 35-55) suppresses spontaneous regeneration of dopaminergic neurons injured with 1-methyl-4 phenyl-1,2,3,6-tetrahydropiridine (MPTP).
Acta Neurobiol. Exp. (Wars) 63 , 109-115, (2003) The pathological process of neurodegeneration is accompanied by an inflammatory reaction that is believed to contribute to the pathogenesis of neurodegenerative diseases. The aim of our study was to e... |
| Myelin oligodendrocyte glycoprotein mouse rat 35-55 |
| DNA (human 35-55-myelin-oligodendroglial glycoprotein MOG-specifying) |
| Deoxyribonucleic acid (human 35-55-myelin-oligodendroglial glycoprotein MOG-specifying) |
| DNA (human 35-55-myelin-oligodendroglial glycoprotein MOG-specifying cDNA) |